证券之星消息,根据天眼查APP数据显示康希诺(688185)新获得一项发明专利授权,专利名为“免疫原性组合物、百白破联合疫苗及其制备方法和应用”,专利申请号为CN202510104180.6,授权日为2025年9月23日。专利摘要:本发明提供一种免疫原性组合物以及百日咳(三组分)、白喉、破伤风联合疫苗,尤其是一种具有提高免疫反应的百白破疫苗。本发明的免疫原性组合物和疫苗含有特别选择的双铝基佐剂,...
Source Link证券之星消息,根据天眼查APP数据显示康希诺(688185)新获得一项发明专利授权,专利名为“免疫原性组合物、百白破联合疫苗及其制备方法和应用”,专利申请号为CN202510104180.6,授权日为2025年9月23日。专利摘要:本发明提供一种免疫原性组合物以及百日咳(三组分)、白喉、破伤风联合疫苗,尤其是一种具有提高免疫反应的百白破疫苗。本发明的免疫原性组合物和疫苗含有特别选择的双铝基佐剂,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.